Effect of Membrane Potential on Sodium-Channel Inhibition
(A) Schematic representation of patch clamp experiments carried out in isolated atrial cardiomyocytes. Human embryonic kidney (HEK) cells were patch clamped using the same setup. (B) Representative traces showing INa measured by patch clamping in isolated atrial cardiomyocytes, at baseline and with flecainide, at increasing holding potentials (–100 to –65 mV). (C) Reduction in peak INa was enhanced with increased holding potentials, irrespective of cardiomyocyte origin. (D) Representative traces showing INa in Nav1.5-transfected HEK cells at baseline and with flecainide at increasing holding potentials (–100 to –65 mV). (E) Reduction in peak INa with flecainide in Nav1.5-transfected HEK cells was enhanced with increased holding potentials. The greatest difference in percent reduction was between –70 and –65 mV. Abbreviations as in Figures 1, 2, and 3.